A detailed history of Lee Danner & Bass Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Lee Danner & Bass Inc holds 494 shares of LLY stock, worth $374,224. This represents 0.03% of its overall portfolio holdings.

Number of Shares
494
Previous 494 -0.0%
Holding current value
$374,224
Previous $447,000 2.01%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $5,777 - $6,810
11 Added 2.28%
494 $288,000
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $169,407 - $226,517
483 New
483 $227,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $720B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lee Danner & Bass Inc Portfolio

Follow Lee Danner & Bass Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.